Pulsenmore
Pulsenmore is an Israeli medical equipment company that specializes in self-scan ultrasound devices aimed at remote clinical diagnosis and screening. The company is publicly traded on the Tel-Aviv Stock Exchange under the ticker symbol PULS. Pulsenmore focuses on enhancing prenatal care through home ultrasound solutions, which improve patient access and resource management in healthcare systems. The company's flagship product, the Pulsenmore ES, allows expectant mothers to perform basic ultrasound assessments at home. This device can be used with real-time clinician guidance or through self-scan protocols via a mobile app. Pulsenmore also has plans to develop additional home ultrasound solutions for women undergoing IVF and patients with congestive heart failure. The company has formed significant partnerships, including a multi-million-dollar agreement with Clalit Health Services and a $21 million investment from GE HealthCare, highlighting its integration into mainstream healthcare.
Work at Pulsenmore in HR or recruiting? Claim this page
Headcount trend
Pulsenmore went from 58 employees in Apr 2023 to 61 in Mar 2025. Oct 2024 to Mar 2025: 2 people joined, 0 left.
Headcount data through Mar 2025
Org structure
Headcount by department
Peer reviews
Worked with someone at Pulsenmore?
Anonymous peer reviews on OffTheRecord
Similar companies
Pulsenmore FAQ
How many employees does Pulsenmore have?
Pulsenmore has about 61 employees, up 1.7% over the 3 months to Mar 2025.
Is Pulsenmore a public company?
Yes. Pulsenmore is publicly traded under the ticker PULS.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.